Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson's disease

被引：0
|
作者：
Fabbri, M.
Chatkaew, P.
Artusi, C.
Romagnolo, A.
Rizzone, M.
Zibetti, M.
Lopiano, L.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
865
引用
收藏
页码：S343 / S344
页数：2
相关论文
共 50 条
  • [21] Long-term safety by levodopa dose in phase 3 trials of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease
    Boyd, J. T.
    Rodriguez, R. L.
    Hall, C.
    Eaton, S.
    Dubow, J.
    Benesh, J.
    MOVEMENT DISORDERS, 2014, 29 : S229 - S229
  • [22] Video analysis of long-term effects of levodopa-carbidopa intestinal gel on gait and posture in advanced Parkinson’s disease
    Margherita Fabbri
    Chatkaew Pongmala
    Carlo Alberto Artusi
    Gabriele Imbalzano
    Alberto Romagnolo
    Leonardo Lopiano
    Maurizio Zibetti
    Neurological Sciences, 2020, 41 : 1927 - 1930
  • [23] Levodopa-Carbidopa Intestinal Gel Improves Long-term Parkinson's Disease Symptoms: Final Analysis of the DUOGLOBE Study
    Chaudhuri, K.
    Kovacs, N.
    Pontieri, F.
    Aldred, J.
    Bourgeois, P.
    Davis, T.
    Cubo, E.
    Anca-Herschkovitsch, M.
    Iansek, R.
    Siddiqui, M.
    Simu, M.
    Bergmann, L.
    Kukreja, P.
    Ladhani, O.
    Jia, J.
    Standaert, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 449 - 450
  • [24] Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
    Antonini, Angelo
    Fung, Victor S. C.
    Boyd, James T.
    Slevin, John T.
    Hall, Coleen
    Chatamra, Krai
    Eaton, Susan
    Benesh, Janet A.
    MOVEMENT DISORDERS, 2016, 31 (04) : 530 - 537
  • [25] Long-term safety and effectiveness of levodopa-carbidopa intestinal gel infusion
    De Fabregues, Oriol
    Dot, Joan
    Abu-Suboh, Monder
    Hernandez-Vara, Jorge
    Ferre, Alex
    Romero, Odile
    Ibarria, Marta
    Luis Seoane, Jose
    Raguer, Nuria
    Puiggros, Carolina
    Rosa Gomez, Maria
    Quintana, Manuel
    Ramon Armengol, Josep
    Alvarez-Sabin, Jose
    BRAIN AND BEHAVIOR, 2017, 7 (08):
  • [26] Efficacy and safety of Levodopa-Carbidopa Intestinal Gel in the treatment of Parkinson's Disease
    Londero, E.
    dos Santos, A. P.
    Braga, R.
    de Barros, R.
    dos Reis, L.
    Freire, G.
    MOVEMENT DISORDERS, 2021, 36 : S220 - S220
  • [27] Suicide in Parkinson's Disease Patients Treated With Levodopa-Carbidopa Intestinal Gel
    Zorko, Nika
    Kojovic, Maja
    Flisar, Dusan
    Pirtosek, Zvezdan
    Kramberger, Milica Gregoric
    MOVEMENT DISORDERS, 2015, 30 (10) : 1434 - 1435
  • [28] Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review
    Wirdefeldt, Karin
    Odin, Per
    Nyholm, Dag
    CNS DRUGS, 2016, 30 (05) : 381 - 404
  • [29] The effect of levodopa-carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson's disease: a multicenter Romanian experience
    Bajenaru, O.
    Ene, A.
    Popescu, B. O.
    Szasz, J. A.
    Sabau, M.
    Muresan, D. F.
    Perju-Dumbrava, L.
    Popescu, C. D.
    Constantinescu, A.
    Buraga, I.
    Simu, M.
    JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (04) : 407 - 414
  • [30] Long-term safety from phase 3 trials of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease
    Rodriguez, R. L.
    Schmulewitz, N.
    Hall, C.
    Eaton, S.
    Dubow, J.
    Benesh, J.
    MOVEMENT DISORDERS, 2014, 29 : S263 - S263
12345